The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
The price of Neumora Therapeutics Inc (NASDAQ: NMRA) closed at $2.05 in the last session, down -5.53% from day before closing price of $2.17. In other words, the price has decreased by -$5.53 from its previous closing price. On the day, 4.64 million shares were traded. NMRA stock price reached its highest trading level at $2.19 during the session, while it also had its lowest trading level at $2.0.
Ratios:
We take a closer look at NMRA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 10.98 and its Current Ratio is at 10.98. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, RBC Capital Mkts on January 02, 2025, Downgraded its rating to Sector Perform and sets its target price to $4 from $29 previously.
On November 05, 2024, JP Morgan Downgraded its rating to Neutral which previously was Overweight and also lowered its target price recommendation from $18 to $15.
On October 01, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $30.H.C. Wainwright initiated its Buy rating on October 01, 2024, with a $30 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Oct 18 ’24 when Fust Matthew K sold 14,049 shares for $17.03 per share. The transaction valued at 239,319 led to the insider holds 20,100 shares of the business.
Fust Matthew K sold 7,739 shares of NMRA for $131,643 on Oct 17 ’24. The Director now owns 20,100 shares after completing the transaction at $17.01 per share. On Oct 18 ’24, another insider, Fust Matthew K, who serves as the Director of the company, bought 14,049 shares for $17.03 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NMRA now has a Market Capitalization of 331200032 and an Enterprise Value of -39975120.
Stock Price History:
The Beta on a monthly basis for NMRA is 3.24, which has changed by -0.86909324 over the last 52 weeks, in comparison to a change of 0.23631513 over the same period for the S&P500. Over the past 52 weeks, NMRA has reached a high of $21.00, while it has fallen to a 52-week low of $1.83. The 50-Day Moving Average of the stock is -76.87%, while the 200-Day Moving Average is calculated to be -81.04%.
Shares Statistics:
According to the various share statistics, NMRA traded on average about 2.71M shares per day over the past 3-months and 7175700 shares per day over the past 10 days. A total of 160.48M shares are outstanding, with a floating share count of 55.17M. Insiders hold about 65.85% of the company’s shares, while institutions hold 29.80% stake in the company. Shares short for NMRA as of 1735603200 were 12989499 with a Short Ratio of 4.80, compared to 1732838400 on 10457148. Therefore, it implies a Short% of Shares Outstanding of 12989499 and a Short% of Float of 15.21.
